Product Information
METOCLOPRAMIDE 10 MG/2 ML VIAL is a generic product labeled by Teva Parenteral Medicines, Inc., priced at $0.5290 per ML under NDC 00703450204. Its NADAC has been published 186 times since May 18, 2016.
FDA first approved this application on Nov 27, 1991. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Metoclopramide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Teva Parenteral Medicines, Inc.NDC
00703450204
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
7/22/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA073135FDA Approved
11/27/1991
TE Code
AP
On Market Since
12/1/1991
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has been published 186 times since May 18, 2016, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5290 per ML |
|---|---|
| All-time high | $0.6016 (May 14, 2025) |
| All-time low | $0.4971 (Jun 19, 2024) |
| 52-week high | $0.5732 |
| 52-week low | $0.5178 |
| Median price | $0.5249 |
| Average price | $0.5374 |
| Largest weekly change | +18.7% (Sep 18, 2024) |
| Weeks tracked | 186 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Metoclopramide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Parenteral Medicines, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoclopramide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dopamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 10 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG/2 ML VIAL, manufactured by Teva Parenteral Medicines, Inc., is $0.5290 per ML (NDC 00703450204), effective Sep 30, 2026.
How has the price of METOCLOPRAMIDE 10 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has risen 5.7%. It has been tracked across 186 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG/2 ML VIAL?
Since May 18, 2016, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has ranged from a low of $0.4971 (Jun 19, 2024) to a high of $0.6016 (May 14, 2025), with a median of $0.5249 per ML.
Are there cheaper alternatives to METOCLOPRAMIDE 10 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of METOCLOPRAMIDE 10 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METOCLOPRAMIDE 10 MG/2 ML VIAL?
METOCLOPRAMIDE 10 MG/2 ML VIAL (NDC 00703450204) is labeled by Teva Parenteral Medicines, Inc., and CMS classifies it as a generic product.